Ajit Singh

Ajit Singh joined Flagship in 2025 and serves as CEO-Partner and CEO of Harbinger Health, where he has been a board member since 2024. 

Ajit Singh was most recently a Partner at Artiman Ventures, where he focused on early-stage technology and life science investments and represented the firm on the boards of Aditazz, CORE Diagnostics, and OncoStem Diagnostics. In addition, Ajit serves as an Adjunct Professor in the School of Medicine at Stanford University and serves on the Board of Trustees of the American Association for Cancer Research (AACR).

Before joining Artiman, Ajit was the President and CEO of BioImagene (acquired by Roche), and earlier, he spent nearly twenty years at Siemens. During his tenure at Siemens, Ajit held various roles, most recently as the Chief Executive Officer of the Digital Radiology and Medical Informatics business of Siemens Healthcare.

Ajit holds a Ph.D. in Computer Science from Columbia University, an M.S. in Computer Engineering from Syracuse University, and a B.A. in Electrical Engineering from Banaras Hindu University, India. He has published two books and numerous refereed articles and holds five patents.